Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:NRXSNASDAQ:NXLNASDAQ:STRRNASDAQ:VRAY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNRXSNeurAxis$2.27-1.3%$2.08$1.33▼$3.78$16.60M3.3418,646 shs10,667 shsNXLNexalin Technology$1.22+2.5%$1.82$0.53▼$4.49$16.26M4.671.24 million shs70,700 shsSTRRStar Equity$2.35+4.4%$2.18$1.72▼$5.35$7.56M0.8714,835 shs22,189 shsVRAYViewRay$0.34$0.02▼$4.96$4.59M0.817.51 million shs108.50 million shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNRXSNeurAxis-1.30%+8.87%+31.21%-6.39%-24.33%NXLNexalin Technology+2.52%-2.40%-31.46%-61.99%-10.95%STRRStar Equity+4.44%-0.21%+17.50%+10.33%-47.78%VRAYViewRay0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationNRXSNeurAxisN/AN/AN/AN/AN/AN/AN/AN/ANXLNexalin Technology3.0497 of 5 stars3.55.00.00.01.93.30.0STRRStar Equity1.3525 of 5 stars0.05.00.00.01.01.71.3VRAYViewRayN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceNRXSNeurAxis 0.00N/AN/AN/ANXLNexalin Technology 3.00Buy$5.00309.84% UpsideSTRRStar Equity 0.00N/AN/AN/AVRAYViewRay 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest VRAY, NRXS, NXL, and STRR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/24/2025NXLNexalin TechnologyMaxim GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy$5.00(Data available from 5/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookNRXSNeurAxis$2.69M6.10N/AN/A($0.27) per share-8.41NXLNexalin Technology$168.72K96.37N/AN/A$0.43 per share2.84STRRStar Equity$53.36M0.14$0.38 per share6.11$14.63 per share0.16VRAYViewRay$105.86M0.00N/AN/A$0.45 per share0.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateNRXSNeurAxis-$14.63M-$1.19N/A∞N/A-492.76%N/A-641.25%5/19/2025 (Estimated)NXLNexalin Technology-$4.65M-$0.82N/A∞N/A-3,407.98%-187.59%-167.21%N/ASTRRStar Equity$25.13M-$3.91N/AN/AN/A-12.41%-8.72%-4.62%N/AVRAYViewRay-$107.33M-$0.60N/AN/AN/A-104.30%-120.48%-42.39%N/ALatest VRAY, NRXS, NXL, and STRR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025STRRStar Equity-$0.25-$0.52-$0.27-$0.37$16.35 millionN/A5/13/2025Q1 2025NXLNexalin TechnologyN/A-$0.15N/A-$0.15N/A$0.04 million3/20/2025Q4 2024STRRStar Equity-$0.17$0.15+$0.32-$0.94$14.00 million$17.10 million3/14/2025Q4 2024NXLNexalin TechnologyN/A-$0.28N/A-$0.28N/A$0.03 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthNRXSNeurAxisN/AN/AN/AN/AN/ANXLNexalin TechnologyN/AN/AN/AN/AN/ASTRRStar EquityN/AN/AN/AN/AN/AVRAYViewRayN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioNRXSNeurAxisN/A0.240.23NXLNexalin TechnologyN/A16.4215.89STRRStar Equity0.212.051.60VRAYViewRayN/A1.160.91Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipNRXSNeurAxis11.77%NXLNexalin Technology0.65%STRRStar Equity3.84%VRAYViewRay92.97%Insider OwnershipCompanyInsider OwnershipNRXSNeurAxis26.40%NXLNexalin Technology24.00%STRRStar Equity33.51%VRAYViewRay2.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableNRXSNeurAxis197.22 million6.09 millionNot OptionableNXLNexalin Technology313.33 million10.11 millionNot OptionableSTRRStar Equity4603.22 million2.14 millionNot OptionableVRAYViewRay295183.40 million178.82 millionOptionableVRAY, NRXS, NXL, and STRR HeadlinesRecent News About These CompaniesRay Martin dives into the world of death and funerals in 'The Last Goodbye'August 1, 2024 | sbs.com.auViewRay Inc (VRAYQ) Earnings Dates & ReportsMay 27, 2024 | investing.comThe best 4K Blu-ray players for 2024March 24, 2024 | digitaltrends.comVRAY Jan 2025 2.000 callMarch 16, 2024 | finance.yahoo.comVRAY Jan 2025 0.500 putMarch 16, 2024 | finance.yahoo.comVRAY Jan 2025 0.500 callMarch 16, 2024 | finance.yahoo.comVRAY Jan 2025 3.000 putMarch 16, 2024 | finance.yahoo.comCreating the Scene with V-Ray for 3ds MaxMarch 2, 2024 | archdaily.comHow to Supercharge Your SketchUp Renders With V-Ray Lights and MaterialsFebruary 26, 2024 | archdaily.comViewRay Inc VRAYQNovember 4, 2023 | morningstar.comNUBURU Appoints Brian Knaley as new CEONovember 1, 2023 | benzinga.comOpen Letter to ViewRay Customers, Service, Software Engineers and Suppliers-Let's Preserve ViewRay TechnologyOctober 19, 2023 | tmcnet.comLetter to ViewRay Lenders/Investment Bankers and Customers From Krishnan Suthanthiran, President/Founder of TeamBest Global CompaniesOctober 17, 2023 | benzinga.comViewRay Inc (6L9.BE)August 20, 2023 | ca.finance.yahoo.comB. Riley Securities downgrades ViewRay Inc. (VRAY) rating to a NeutralJuly 24, 2023 | knoxdaily.comViewRay stock to be delisted from Nasdaq and moved to OTC ExchangeJuly 21, 2023 | seekingalpha.comViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC MarketsJuly 21, 2023 | finance.yahoo.comKeeping an Eye on ViewRay Inc. (VRAY) After Insider Trading ActivityJuly 19, 2023 | knoxdaily.comWhy ViewRay Stock Hit A New 52-Week Low TodayJuly 18, 2023 | benzinga.comViewRay, Inc.: ViewRay Files Voluntary Chapter 11 PetitionsJuly 18, 2023 | finanznachrichten.deNew MarketBeat Followers Over TimeMedia Sentiment Over TimeVRAY, NRXS, NXL, and STRR Company DescriptionsNeurAxis NASDAQ:NRXS$2.27 -0.03 (-1.30%) As of 05/14/2025 03:59 PM EasternNeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.Nexalin Technology NASDAQ:NXL$1.22 +0.03 (+2.52%) As of 05/14/2025 03:59 PM EasternNexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.Star Equity NASDAQ:STRR$2.35 +0.10 (+4.44%) As of 05/14/2025 01:47 PM EasternStar Equity Holdings, Inc. engages in the construction business in the United States and internationally. It operates through two segments: Construction, and Investments. It manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; holds real estate assets; and manages investments. The company was formerly known as Digirad Corporation and changed its name to Star Equity Holdings, Inc. in December 2020. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Old Greenwich, Connecticut.ViewRay NASDAQ:VRAYViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, Italy, France, Taiwan, the United Kingdom, and internationally. It provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers through a network of direct sales force and distributors. ViewRay, Inc. was founded in 2004 and is headquartered in Denver, Colorado. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SMCI Stock Rally: 45% Gain in 2 Days Could Be Just the Start AMD’s AI-Powered Stock Price Rally Just Shifted Gears Oklo Reaches Critical Mass, Atomic Upside Still Available Is Verizon a Buy? Q1 Results and Solid Dividend Make Bullish Case Carnival's Comeback: Is the Stock Set for a Profitable Journey? 5 Hot Small-Cap Insiders Bought at the Peak of Tariff Fears U.S. Regulators Target CrowdStrike: Is It a Signal or Noise? Insulet Surges on Q1 Beat, Emerges as a Top S&P 500 Performer Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
